Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
03/1998
03/17/1998US5728739 Ligands with affinity for retinoic acid receptors in synergistic combination with a fatty acid, treatment of diabetes, cardiovascular disease, atherosclerosis
03/17/1998US5728736 Applying an arginase inhibitor to the skin
03/17/1998US5728719 Systemic control of parasites
03/17/1998US5728687 Antitumour compositions containing taxane derivatives
03/17/1998US5728684 Determination of prodrugs metabolizable by the liver and therapeutic use thereof
03/17/1998US5728681 Infusion preparation and two compartment container containing the preparation
03/17/1998US5728541 Screening therapeutic or chemotherapeutic agents for efficacy as to a specific patient
03/17/1998US5728534 Screening assays involving effect of candidate agent on cell proliferation/activation and on expression of gene responsive to estrogen
03/17/1998US5728523 Polymerase delta mutations in colorectal tumors with replication errors
03/17/1998US5728405 Method for preventing keratocyte loss
03/17/1998US5728396 Sustained delivery of leuprolide using an implantable system
03/17/1998US5728393 Cosmetic slimming by inhibiting glucose uptake
03/17/1998US5728378 Antitumor and antivirus agents
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/12/1998WO1998010068A2 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998WO1998010058A1 Human cns cell lines and methods of use therefor
03/12/1998WO1998009653A1 Association of no syntase inhibitors with trappers of oxygen reactive forms
03/12/1998WO1998009652A1 COMPOSITION, ANTIMICROBIAL AGENT, INFECTION PREVENTIVE, AND FOOD AGAINST $i(HELICOBACTER PYLORI)
03/12/1998WO1998009650A1 Vaccinal preparations
03/12/1998WO1998009647A2 Cyanidin compositions and therapeutic and diagnostic uses therefor
03/12/1998WO1998009632A1 Methods and compositions for treating preterm labor
03/12/1998WO1998009631A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol
03/12/1998WO1998009626A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998WO1998009618A2 Graft survival prolongation with porphyrins
03/12/1998WO1998005792A3 A novel human leptin receptor gene-related protein
03/12/1998WO1998004709A3 Herpes simplex virus ICP4 is an inhibitor of apoptosis
03/12/1998WO1998004585A3 Novel human macrophage antigen
03/12/1998WO1998001563A3 Adenovirus e4 proteins for inducing cell death
03/12/1998WO1997046682A3 Polynucleotides from human adult PBMC encoding secreted proteins
03/12/1998DE19636889A1 Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel Antineoplastic acting transferrin and albumin conjugates cytostatic compounds from the group of anthracyclines, alkylating agents, antimetabolites and cisplatin analogues and pharmaceutical compositions containing them
03/12/1998CA2264965A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals
03/12/1998CA2264273A1 Human cns cell lines and methods of use therefor
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2261655A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol
03/12/1998CA2234886A1 Graft survival prolongation with porphyrins
03/12/1998CA2215015A1 Treating prostate hypertrophy and prostate cancer
03/11/1998EP0827964A2 S-(+)-adenosylmethionine and 3'-azido-2',3'-dideoxy-nucleo-side complexes as potent inhibitors of HIV-replication
03/11/1998EP0827745A1 Anti-tumour compositions containing taxan derivatives
03/11/1998EP0827743A1 Use of histone decarboxylase inhibitors for treating fibrosis
03/11/1998EP0827742A1 Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
03/11/1998EP0827410A1 Method for introducing and expressing genes in animal cells
03/11/1998EP0827403A1 Use of calcium intracellular store inactivators and formulations thereof as cell growth inhibitors
03/11/1998EP0827401A2 Methods and compositions for inhibiting alpha-reductase activity
03/11/1998EP0827397A2 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application
03/11/1998EP0827396A1 Production scale method of forming microparticles
03/11/1998EP0556178B1 Use of protease nexin-i to mediate wound healing
03/11/1998CN1175903A Method of treating adenosine depletion
03/10/1998US5726156 Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
03/10/1998US5725880 Pharmaceutical preparation controlled to release medicinal active ingredient at targeted site in intestinal tract
03/10/1998US5725844 Hydrophobic pigments and fillers for films
03/10/1998US5725839 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
03/10/1998US5724995 Method for screening factors on a paralysis model and method for obtaining this model
03/05/1998WO1998009170A2 Methods and compositions for the detection of cervical cancer
03/05/1998WO1998008957A1 Compositions and methods for specifically targeting tumors
03/05/1998WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome
03/05/1998WO1998008937A1 Method for sorting antifungal molecules acting on the glucanosyltransferase activity
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008546A2 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998WO1998008545A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998WO1998008536A2 Method of reducing the severity of host vs. graft reaction by down-regulating hsp60 autoimmunity
03/05/1998WO1998008532A1 Methods of treating renal disease with a gastrin releasing peptide receptor antagonist
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008518A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998WO1998008509A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
03/05/1998WO1998008494A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
03/05/1998WO1998008490A1 Solid coprecipitates for enhanced bioavailability of lipophilic substances
03/05/1998WO1997047296A3 Compositions comprising vanadium compounds for use in the treatment of proliferative disorders and arthropathies
03/05/1998WO1997046226A3 USE OF INHIBITORS OF THE CELLULAR Na+/H+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS
03/05/1998WO1997037688A3 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
03/05/1998DE19635883A1 Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination Transdermal therapeutic system with a combination of active ingredients containing estriol
03/05/1998CA2264715A1 Methods and compositions for the treatment of bone resorption disorders, including osteoporosis
03/05/1998CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998CA2263998A1 Compositions and methods for administering integrin receptor antagonists
03/05/1998CA2263935A1 Methods for treating disorders by using interleukin-9 and its antagonists
03/05/1998CA2263827A1 Fibroblast growth factor homologous factors (fhfs) and methods of use
03/05/1998CA2263817A1 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
03/05/1998CA2263133A1 Use of pkc inhibitors for the manufacture of a medicament for the treatment of aids
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level
03/04/1998EP0826041A1 Transforming growth factor alpha hii
03/04/1998EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
03/04/1998EP0825863A1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
03/04/1998EP0825856A1 Irritation relief using nonsteroidal anti-inflammatory compounds
03/04/1998EP0825853A1 Prolonged nerve blockage by the combination of local anesthetics and glucocorticoids
03/04/1998EP0825848A1 Novel collagen formulations
03/04/1998EP0692962B1 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses
03/04/1998EP0616523B1 Medicaments
03/04/1998CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/04/1998CN1175214A Petide P227 analogs, and pharmaceutical compositions comprising them for treatment or diagnosis of diabetes
03/04/1998CN1175213A Irrigation solution and method for inhibition of pain, inflammation
03/04/1998CN1174742A Complex cow's milk gamma globulin and the making method thereof
03/03/1998US5723449 Antisecretory agents and anticarcinogenic agents
03/03/1998US5723448 Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
03/03/1998US5723291 Methods for screening compounds for estrogenic activity
03/03/1998US5723146 Pharmaceutical preparations
03/03/1998US5723144 Ointment for wound treatment
02/1998
02/26/1998WO1998008101A1 Materials and methods for detection and treatment of immune system dysfunctions
02/26/1998WO1998007850A2 Agents for pre-symptomatic detection and therapeutic targeting of alzheimer's disease and down syndrome in humans
02/26/1998WO1998007832A1 Recombinant vascular endothelial cell growth factor d (vegf-d)
1 ... 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 ... 1151